z-logo
open-access-imgOpen Access
A Randomized Controlled Trial of Etilevodopa in Patients With Parkinson Disease Who Have Motor Fluctuations
Author(s) -
Karen Blindauer,
Ira Shoulson,
David Oakes,
Karl Kieburtz,
Steven Schwid,
Stanley Fahn,
Matthew Stern,
Christopher G. Goetz,
John G. Nutt,
Sari Goren,
N. Sayag,
M. Scolnik,
R. Levy,
Eli Eyal,
Phyllis Salzman,
Mary Pagano
Publication year - 2006
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneur.63.2.210
Subject(s) - carbidopa , levodopa , gastric emptying , tolerability , parkinson's disease , medicine , randomized controlled trial , dosing , anesthesia , adverse effect , stomach , disease
Motor fluctuations are a common complication in patients with Parkinson disease (PD) receiving long-term levodopa therapy. Slowed gastric emptying and poor solubility of levodopa in the gastrointestinal tract may delay the onset of drug benefit after dosing. Etilevodopa is an ethyl-ester prodrug of levodopa that has greater gastric solubility, passes quickly into the small intestine, is rapidly hydrolyzed to levodopa, and has a shortened time to maximum levodopa concentration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom